Dysglycemia in Children with Severe Acute Malnutrition: A Systematic Review and Meta-Analysis

Elizabeth Ledger1, Philliness Prisca Harawa2,3, Allison I Daniel4,5

  • 1Medical Research Council The Gambia at the London School of Hygiene & Tropical Medicine, Keppel Street, London, UK.

Insights

Hypoglycemia affects 9% of children with severe acute malnutrition (SAM) and significantly increases their mortality risk. Further research is needed to understand dysglycemia

Area of Science:

  • Pediatric Endocrinology
  • Global Health
  • Nutritional Science

Background:

  • Dysglycemia, including hypoglycemia and hyperglycemia, is a frequent complication in children with severe acute malnutrition (SAM).
  • The prevalence and clinical impact of dysglycemia in hospitalized children with SAM remain incompletely understood.
  • Understanding these metabolic disturbances is crucial for improving patient outcomes.

Purpose of the Study:

  • To systematically review and quantify the prevalence of hypoglycemia and hyperglycemia in hospitalized children with SAM.
  • To investigate the association between dysglycemia and clinical outcomes, particularly mortality, in this vulnerable population.
  • To evaluate the certainty of the existing evidence regarding dysglycemia in SAM.

Main Methods:

  • A systematic literature search was conducted using MEDLINE with terms related to children, SAM, and dysglycemia.
  • Meta-analyses of proportions were performed to determine hypoglycemia prevalence and its association with mortality.
  • The Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach was used to assess the certainty of the evidence.

Main Results:

  • The pooled prevalence of hypoglycemia in children with SAM was 9% (95% CI: 7%, 12%), with low certainty evidence.
  • Hypoglycemia was significantly associated with increased mortality risk during hospitalization (OR: 4.29; 95% CI: 3.04, 6.05), with moderate certainty evidence.
  • Hyperglycemia prevalence varied widely (2%-38%) due to inconsistent definitions, with very low certainty evidence.

Conclusions:

  • Hypoglycemia is a common and serious complication in hospitalized children with SAM, linked to higher mortality.
  • The evidence for hyperglycemia prevalence and its outcomes in SAM is limited and of very low certainty.
  • Further research employing standardized glucose monitoring is essential to clarify the clinical significance of dysglycemia in SAM.

Related Concept Videos

Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
651
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
1.7K
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
4.5K
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.0K
Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
488
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
2.6K